|
FASTKD5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62725388719309E-12 |
| Normal-vs-Stage2 |
2.62519999960631E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.738300E-03 |
| Stage1-vs-Stage3 |
6.515900E-02 |
| Stage1-vs-Stage4 |
5.229600E-04 |
| Stage2-vs-Stage3 |
4.174300E-04 |
| Stage2-vs-Stage4 |
2.51539999995831E-06 |
| Stage3-vs-Stage4 |
7.539600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.15549999568643E-08 |
| Normal-vs-Asian |
8.65896243595898E-12 |
| Caucasian-vs-AfricanAmerican |
5.678400E-01 |
| Caucasian-vs-Asian |
1.895990E-01 |
| AfricanAmerican-vs-Asian |
7.179000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62581059726108E-12 |
| Male-vs-Female |
5.160200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62569957495862E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(81-100Yrs) |
2.08130000000084E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.218800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.293600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.629600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.404800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.893000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.078000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.96230000000442E-05 |
| Classical-VS-Follicular |
7.924600E-03 |
| Classical-VS-Other |
7.800500E-02 |
| Classical-VS-Normal |
1.63258295771129E-12 |
| Tall-VS-Follicular |
1.33250000033946E-07 |
| Tall-VS-Other |
8.651400E-01 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
1.896430E-02 |
| Follicular-VS-Normal |
4.00820487911346E-11 |
| Other-VS-Normal |
9.83860000025594E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
8.767600E-04 |
|
|
